Advertisement

Employment/Membership › Details
Gilde Investment–von Berg M: management, 202207– Investment Manager at Gilde Healthcare in Ffm before 3i + Halder + BofA
![]() |
Period | 2022-07-01 |
![]() |
Region | Frankfurt am Main |
Country | Germany | |
![]() |
Organisation | Gilde Healthcare, Frankfurt Office |
Group | Gilde Investment (Group) | |
![]() |
Product | private equity |
Product 2 | healthcare | |
![]() |
Person | von Berg, Martin (Gilde Investment, 202207– Investment Manager at Gilde Healthcare in Ffm before 3i + Halder + BofA) |
Gilde Healthcare Partners. (7/12/22). "Press Release: Gilde Healthcare Bolsters Its Private Equity Team in Frankfurt Office". Utrecht & Frankfurt a. M..
Dutch sector specialist Gilde Healthcare announces two new hires to its private equity team in Germany, following the recent close of its new €518m lower mid-market fund Gilde Healthcare Private Equity IV.
With the recruitment of Martin von Berg as Investment Manager and Lara Hilgert as Investment Analyst, the firm continues to expand its team in the region, following the arrival Robert Stein as Partner in 2021. Before joining Gilde Healthcare, Martin gained more than 5 years of private equity experience at 3i and Halder, where he was involved in healthcare services transactions. Martin started his career in the investment banking team of Bank of America in Frankfurt after graduating from the University of Mannheim with a MSc in Management. Lara joins Gilde Healthcare after finishing her MSc in Management at the London School of Economics. She successfully completed an internship at Gilde Healthcare last year and gained additional working experience at Roland Berger, Greenhill and PWC.
Gilde Healthcare completed four private equity transactions in Germany in the last 18 months and considers additional hires in the coming period.
About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €1.9 billion across two fund strategies: Private Equity and Venture&Growth. The firm is headquartered in Utrecht (The Netherlands) with local offices in Frankfurt (Germany) and Cambridge (United States). The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. The Private Equity fund targets healthcare providers, suppliers of medical products and service providers to pharma, medtech and healthcare. Gilde Healthcare’s Venture&Growth fund invests in therapeutics, medtech and healthtech in Europe and North America. Further information at www.gildehealthcare.com
Record changed: 2023-01-01 |
Advertisement

More documents for Gilde Investment (Group)
- [1] Gilde Healthcare Partners. (8/29/22). "Press Release: Gilde Healthcare Acquires Sanquin Reagents". Utrecht....
- [2] Gilde Healthcare Partners. (7/12/22). "Press Release: Gilde Healthcare Bolsters Its Private Equity Team in Frankfurt Office". Utrecht & Frankfurt a. M.....
- [3] Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden....
- [4] Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht....
- [5] Gilde Healthcare Partners. (12/14/21). "Press Release: Philips Acquires Gilde Portfolio Company Vesper Medical to Further Expand Its Image-guided Therapy Devices Portfolio". Amsterdam & Utrecht....
- [6] Gilde Healthcare Partners. (6/2/21). "Press Release: Gilde Healthcare Appoints Joep Muijrers to Lead Investments in Public Markets". Utrecht....
- [7] Gilde Healthcare Partners. (5/6/21). "Press Release: Gilde Healthcare Acquires Majority Stake in Danish Drug Development Consultancy KLIFO to Support International Growth Ambitions". Utrecht & Copenhagen....
- [8] Volta Medical. (1/5/21). "Press Release: Volta Medical Raises 28 Million USD to Revolutionize Persistent AFib Ablation". Marseille....
- [9] CVRx, Inc.. (7/7/20). "Press Release: CVRx Raises $50 Million in New Equity Financing. Offering Will Support US Commercialization of Barostem Neo". Minneapolis, MN....
- [10] Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 Million ($450 Million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top